eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 09/01/2012
PIL EMEND 80mg, 125mg hard Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to side-effects
Updated on 20/12/2011 and displayed until 09/01/2012
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/12/2011 and displayed until 20/12/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/11/2011 and displayed until 02/12/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 12/02/2010 and displayed until 22/11/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/08/2009 and displayed until 12/02/2010
Reasons for adding or updating:
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 20/10/2008 and displayed until 25/08/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
Updated on 04/05/2007 and displayed until 20/10/2008
Reasons for adding or updating:
  • Change to how the medicine works
  • Change of special precautions for disposal
  • Change to MA holder contact details
Updated on 17/05/2005 and displayed until 04/05/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to drug interactions
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 10/02/2005 and displayed until 17/05/2005
Reasons for adding or updating:
  • Change to Further Information section
Updated on 20/01/2004 and displayed until 10/02/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  aprepitant